COMMUNIQUÉS West-GlobeNewswire

Lundbeck updates on clinical phase III study for Lu AF35700 in Treatment-Resistant Schizophrenia
25/10/2018
Valby, Oct. 25, 2018 (GLOBE NEWSWIRE) -- Corporate Release Lundbeck updates on clinical phase III study for Lu AF35700 in Treatment-Resistant Schizophrenia Lu AF35700 did not show statistical superiority versus [...]
Long-term incentive program (replacement of company announcement no. 17/2018)
25/10/2018
Company Announcement No. 18/2018 For further information please contact: Martin Riise, Senior Director, Investor Relations, Tel: +45 5339 2250 Camilla Lercke, Head of Media Relations, Tel: +45 5339 2384 About Chr. [...]
Eko Collaborates with Mayo Clinic on a Machine Learning-Based Algorithm to Help Physicians Better Screen for Potentially Dangerous Heart Diseases
25/10/2018
Eko’s software and smart digital stethoscope combined with Mayo’s vast data and tech aims to help physicians with earlier detection of life-threatening conditions Berkeley, CA, Oct. 25, 2018 (GLOBE NEWSWIRE) -- Eko , [...]
Phoenix Life Sciences International Announces Dr. Philip Blair as Diabetes Director of Medical Advisory Council
25/10/2018
DENVER, Oct. 25, 2018 (GLOBE NEWSWIRE) -- Phoenix Life Sciences International Limited (OTCMarkets: MJMD) (“Phoenix Life”), an international adaptive healthcare solutions company, today announced that Col. Philip Blair, [...]
XBiotech annonce le rejet du recours collectif sur les valeurs mobilières
25/10/2018
AUSTIN, Texas, 25 oct. 2018 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ : XBIT) a annoncé aujourd’hui que l’Honorable juge Dustin M. Howell de la 459 e Cour de district du Comté de Travis a rendu sa décision dans une [...]
111, Inc. Establishes Strategic Partnerships with Mentholatum China and Zhongxin Pharmaceuticals
25/10/2018
SHANGHAI, China, Oct. 25, 2018 (GLOBE NEWSWIRE) -- 111, Inc. (NASDAQ:YI) ("111" or the "Company"), a leading integrated online and offline healthcare platform, today announced it has established strategic partnerships [...]
CrownBio Releases MuBase® 2.0, An Open Access Database of Immuno-Oncology Murine Models
25/10/2018
Updates enhance user experience, provide comprehensive characterization data, and add new models SAN DIEGO, Oct. 25, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience, a global drug discovery and development services company [...]
Ovid Therapeutics Presents Additional Data and Analyses from the Phase 2 STARS Clinical Trial with OV101 for the Treatment of Angelman Syndrome at the 65th AACAP Annual Meeting
25/10/2018
-- Additional data and analyses suggest that in the OV101 15 mg once-daily dose group, changes in sleep parameters and motor domains contributed to the statistically significant improvement in overall clinical global [...]
VistaGen Therapeutics Acquires Worldwide Rights to Develop and Commercialize PH10, a First-in-Class Intranasally Administered Neuroactive Steroid with Rapid-onset Antidepressant Effects for Major Depressive Disorder Demonstrated in Phase 2a Study
25/10/2018
PH10 demonstrated in Phase 2a study significant antidepressant effects without psychological side effects after only one week of administration SOUTH SAN FRANCISCO, Calif., Oct. 25, 2018 (GLOBE NEWSWIRE) -- VistaGen [...]
Cellular Biomedicine Group to Provide Company Cancer Immunotherapy Pipeline Update and Facility Tour for Attendees of the Advanced Cell Therapy Summit in Shanghai
25/10/2018
SHANGHAI, China and CUPERTINO, Calif., Oct. 25, 2018 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc . (NASDAQ: CBMG) (“CBMG” or the “Company”), a clinical-stage biopharmaceutical firm engaged in the development of [...]
Tauriga Sciences Inc. Reaches Agreements to Retire the Remainder of its Outstanding Convertible Debt
25/10/2018
New York, Oct. 25, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Tauriga Sciences, Inc. ( TAUG ) (“Tauriga” or the “Company”), engaged in building its business through the development, distribution, and licensing of [...]
Eisai and Biogen Announce Presentation of Additional Data From the Phase II Clinical Trial of BAN2401 in Early Alzheimer’s Disease at the 2018 Clinical Trials on Alzheimer’s Disease (CTAD) Conference
25/10/2018
TOKYO and CAMBRIDGE, Mass., Oct. 25, 2018 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB) (Headquarters: Cambridge, Massachusetts, United States, CEO: [...]
Press release: ONNI hammas Porvoo dental clinic to become a part of Terveystalo
25/10/2018
On 25 November 2018 Terveystalo has signed an agreement to acquire ONNI hammas dental clinic in Porvoo. The company's employees will be transferred to Terveystalo as old employees and the operations will continue on the [...]
GSW, a Syneos Health Advertising Company, Named Agency of the Year by Modern Healthcare & Ad Age
25/10/2018
Award Season Wins Include Industry Recognition for Digital, Print, Video and Social Media Campaigns COLUMBUS, Ohio, Oct. 25, 2018 (GLOBE NEWSWIRE) -- GSW, a Syneos Health TM Company and industry leader in healthcare [...]
United Health Products Engages Société Générale to Undertake Strategic Review
25/10/2018
HENDERSON, Nev., Oct. 25, 2018 (GLOBE NEWSWIRE) -- United Health Products, Inc. (OTC: UEEC), (“UHP” or the “Company”), manufacturer and marketer of HemoStyp ® , a patented hemostatic gauze for the healthcare and wound [...]
Foundational 10,000 Immunomes Project Uses Mass Cytometry to Establish a Reference Standard for the Human Immune System
25/10/2018
Providing the largest source of standardized, multi-omic immune data from healthy human subjects to accelerate translational research SOUTH SAN FRANCISCO, Calif., Oct. 25, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation ( [...]
Scythian Biosciences Announces Name Change to SOL Global Investments Corp.
25/10/2018
TORONTO, Oct. 25, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the " Company ”) (CSE:SCYB) (Frankfurt:9SB) (OTC – Nasdaq Intl:SCCYF) is pleased to announce that the Company has changed its name from “Scythian [...]
Pieris Pharmaceuticals Appoints Matthew L. Sherman, M.D., to its Board of Directors
25/10/2018
BOSTON, Oct. 25, 2018 (GLOBE NEWSWIRE) -- Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS) , a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin ® technology platform for [...]
Genocea to Host Third Quarter 2018 Financial Results Conference Call & Webcast on November 1, 2018 at 9:00 a.m. ET
25/10/2018
CAMBRIDGE, Mass., Oct. 25, 2018 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing personalized cancer immunotherapies, today announced that it will host a conference [...]

Pages